Welcome to our dedicated page for Adia Nutrition news (Ticker: ADIA), a resource for investors and traders seeking the latest updates and insights on Adia Nutrition stock.
ADIA Nutrition Inc. (ADIA) reports developments tied to its regenerative medicine, stem cell therapy, and biologic products business. The company operates through Adia Med clinics, which offer treatments such as PRP, AHSCT, orthopedic care, pain management, and wound repair, and through Adia Labs, which develops and sells biologic products including AdiaVita and AdiaLink.
Company news commonly covers clinical and regulatory activity involving AdiaVita, including study programs in chronic kidney disease, autism spectrum disorder, and chronic lower back pain. Updates also address operating results, product sales and medical-service revenue, capital-structure disclosures, governance matters, and the company's transition from a supplement-oriented business toward regenerative healthcare.
ADIA Nutrition Inc. (OTC Pink: ADIA) has announced the acquisition of Biolete , a company specializing in protein coffee with mushrooms. This strategic move expands ADIA's portfolio in the functional beverage market. The acquisition includes Biolete's trademarks, inventory, customer base, and website. ADIA acquired 100% of Biolete through an equity offer of preferred shares regulated under Rule 144, which doesn't affect current outstanding shares.
Biolete's products combine collagen protein and mushrooms in coffee, offering energy-boosting benefits without negative side effects. The acquisition is expected to immediately contribute to ADIA's earnings and provide new growth opportunities. ADIA plans to integrate Biolete's operations and expand distribution channels to accelerate product adoption.
ADIA Nutrition Inc. (OTC Pink: ADIA) has announced a strategic restructuring, introducing two new divisions: Medical and Supplement. The Medical Division will focus on a clinic for Autologous Hematopoietic Stem Cell Transplantation (AHSCT) for Multiple Sclerosis patients. The Supplement Division aims to acquire or invest in companies producing organic supplements using US manufacturing processes.
CEO Larry Powalisz stated that this restructuring reflects ADIA's commitment to innovation and meeting evolving consumer demands. The company believes these new divisions will drive growth and positively impact individuals' lives. ADIA Nutrition Inc. aims to reinforce its position as a trailblazer in the nutrition industry through this strategic move.